|
Fresenius Medical Care AG & Co. KGaA (FMS) DCF Valuation
DE | Healthcare | Medical - Care Facilities | NYSE
|
- ✓ Fully Editable: Tailor To Your Needs In Excel Or Sheets
- ✓ Professional Design: Trusted, Industry-Standard Templates
- ✓ Pre-Built For Quick And Efficient Use
- ✓ No Expertise Is Needed; Easy To Follow
Fresenius Medical Care AG & Co. KGaA (FMS) Bundle
Whether you're an investor or analyst, this (FMS) DCF Calculator is your essential tool for accurate valuation. Preloaded with real data from Fresenius Medical Care AG & Co. KGaA, you can adjust forecasts and instantly observe the effects.
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2020 |
AY2 2021 |
AY3 2022 |
AY4 2023 |
AY5 2024 |
FY1 2025 |
FY2 2026 |
FY3 2027 |
FY4 2028 |
FY5 2029 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 18,528.4 | 18,279.4 | 20,125.1 | 20,182.8 | 20,060.7 | 20,483.7 | 20,915.7 | 21,356.7 | 21,807.1 | 22,266.9 |
| Revenue Growth, % | 0 | -1.34 | 10.1 | 0.28672 | -0.60507 | 2.11 | 2.11 | 2.11 | 2.11 | 2.11 |
| EBITDA | 4,287.2 | 3,682.2 | 1,639.2 | 3,329.9 | 3,326.4 | 3,462.1 | 3,535.1 | 3,609.6 | 3,685.7 | 3,763.5 |
| EBITDA, % | 23.14 | 20.14 | 8.15 | 16.5 | 16.58 | 16.9 | 16.9 | 16.9 | 16.9 | 16.9 |
| Depreciation | 1,646.4 | 1,644.8 | 1,784.6 | 1,817.6 | 1,807.6 | 1,834.0 | 1,872.7 | 1,912.2 | 1,952.5 | 1,993.7 |
| Depreciation, % | 8.89 | 9 | 8.87 | 9.01 | 9.01 | 8.95 | 8.95 | 8.95 | 8.95 | 8.95 |
| EBIT | 2,640.8 | 2,037.4 | -145.4 | 1,512.3 | 1,518.8 | 1,628.1 | 1,662.4 | 1,697.4 | 1,733.2 | 1,769.8 |
| EBIT, % | 14.25 | 11.15 | -0.72242 | 7.49 | 7.57 | 7.95 | 7.95 | 7.95 | 7.95 | 7.95 |
| Total Cash | 1,289.8 | 1,678.7 | 1,497.9 | 1,597.5 | 1,500.8 | 1,597.1 | 1,630.8 | 1,665.1 | 1,700.3 | 1,736.1 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | 3,386.0 | 3,714.6 | 3,859.3 | 3,774.4 | 4,067.8 | 3,963.6 | 4,047.2 | 4,132.6 | 4,219.7 | 4,308.7 |
| Account Receivables, % | 18.27 | 20.32 | 19.18 | 18.7 | 20.28 | 19.35 | 19.35 | 19.35 | 19.35 | 19.35 |
| Inventories | 1,966.4 | 2,114.4 | 2,382.3 | 2,260.9 | 2,145.4 | 2,290.6 | 2,338.9 | 2,388.3 | 2,438.6 | 2,490.1 |
| Inventories, % | 10.61 | 11.57 | 11.84 | 11.2 | 10.69 | 11.18 | 11.18 | 11.18 | 11.18 | 11.18 |
| Accounts Payable | 824.7 | 849.2 | 926.1 | 870.5 | 1,021.2 | 946.4 | 966.4 | 986.8 | 1,007.6 | 1,028.8 |
| Accounts Payable, % | 4.45 | 4.65 | 4.6 | 4.31 | 5.09 | 4.62 | 4.62 | 4.62 | 4.62 | 4.62 |
| Capital Expenditure | -2,166.3 | -1,746.1 | -1,463.9 | -710.3 | -725.6 | -1,460.6 | -1,491.4 | -1,522.9 | -1,555.0 | -1,587.8 |
| Capital Expenditure, % | -11.69 | -9.55 | -7.27 | -3.52 | -3.62 | -7.13 | -7.13 | -7.13 | -7.13 | -7.13 |
| Tax Rate, % | 49.11 | 49.11 | 49.11 | 49.11 | 49.11 | 49.11 | 49.11 | 49.11 | 49.11 | 49.11 |
| EBITAT | 1,588.3 | 1,256.3 | -80.2 | 730.5 | 773.0 | 899.3 | 918.3 | 937.7 | 957.4 | 977.6 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | -3,459.2 | 702.7 | -95.1 | 1,988.6 | 1,827.6 | 1,156.9 | 1,187.6 | 1,212.7 | 1,238.2 | 1,264.3 |
| WACC, % | 4.59 | 4.63 | 4.47 | 4.3 | 4.36 | 4.47 | 4.47 | 4.47 | 4.47 | 4.47 |
| PV UFCF | ||||||||||
| SUM PV UFCF | 5,314.3 | |||||||||
| Long Term Growth Rate, % | 2.00 | |||||||||
| Free cash flow (T + 1) | 1,290 | |||||||||
| Terminal Value | 52,154 | |||||||||
| Present Terminal Value | 41,906 | |||||||||
| Enterprise Value | 47,220 | |||||||||
| Net Debt | 10,196 | |||||||||
| Equity Value | 37,024 | |||||||||
| Diluted Shares Outstanding, MM | 293 | |||||||||
| Equity Value Per Share | 126.18 |
What You Will Get
- Real FMS Financial Data: Pre-filled with Fresenius Medical Care's historical and projected data for precise analysis.
- Fully Editable Template: Modify key inputs like revenue growth, WACC, and EBITDA % with ease.
- Automatic Calculations: See Fresenius Medical Care's intrinsic value update instantly based on your changes.
- Professional Valuation Tool: Designed for investors, analysts, and consultants seeking accurate DCF results.
- User-Friendly Design: Simple structure and clear instructions for all experience levels.
Key Features
- Customizable Financial Inputs: Adjust essential metrics such as patient growth rates, revenue per treatment, and operational costs.
- Instant DCF Valuation: Quickly computes intrinsic value, NPV, and other financial metrics.
- High-Precision Accuracy: Leverages Fresenius Medical Care’s actual financial data for precise valuation results.
- Effortless Scenario Analysis: Evaluate various scenarios and analyze the results with ease.
- Efficiency Booster: Streamline the valuation process without the need for intricate model development.
How It Works
- Step 1: Download the Excel file for Fresenius Medical Care AG & Co. KGaA (FMS).
- Step 2: Review the pre-filled financial data and forecasts for Fresenius Medical Care.
- Step 3: Adjust key inputs such as revenue growth, WACC, and tax rates (highlighted cells).
- Step 4: Observe the DCF model refresh in real-time as you modify your assumptions.
- Step 5: Evaluate the outputs and leverage the results for your investment strategies.
Why Choose Fresenius Medical Care AG & Co. KGaA (FMS)?
- Enhance Efficiency: Quickly access comprehensive healthcare solutions without the hassle of lengthy procedures.
- Boost Reliability: Our advanced medical technologies ensure precise and dependable patient care.
- Highly Adaptable: Customize services to meet the unique needs of healthcare providers and patients.
- User-Friendly Interface: Intuitive designs and clear information streamline the decision-making process.
- Endorsed by Professionals: Preferred by healthcare experts for its commitment to excellence and innovation.
Who Should Use This Product?
- Healthcare Investors: Develop comprehensive valuation models for analyzing Fresenius Medical Care AG & Co. KGaA (FMS) stock.
- Corporate Finance Teams: Evaluate valuation scenarios to inform strategic decisions within the healthcare sector.
- Consultants and Advisors: Deliver precise valuation insights for clients interested in Fresenius Medical Care AG & Co. KGaA (FMS).
- Students and Educators: Utilize real-world financial data to enhance learning and practice in financial modeling.
- Healthcare Industry Enthusiasts: Gain insights into how healthcare companies like Fresenius Medical Care AG & Co. KGaA (FMS) are valued in the market.
What the Template Contains
- Comprehensive DCF Model: Editable template with detailed valuation calculations tailored for Fresenius Medical Care AG & Co. KGaA (FMS).
- Real-World Data: Fresenius Medical Care's historical and projected financials preloaded for thorough analysis.
- Customizable Parameters: Adjust WACC, growth rates, and tax assumptions to explore various scenarios.
- Financial Statements: Complete annual and quarterly breakdowns for enhanced insights into performance.
- Key Ratios: Integrated analysis for profitability, efficiency, and leverage specific to Fresenius Medical Care.
- Dashboard with Visual Outputs: Charts and tables designed for clear, actionable results specific to (FMS).
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.